NFKB1 and early-onset autosomal dominant Alzheimer disease: For example, rutin reduces glial proliferation and neuroinflammation in the brains of Alzheimer’s disease (AD) mice by downregulating the NF-κB pathway, inhibiting microglial phagocytosis of synapses, reducing synaptic loss, and improving cognitive performance.